Pulmonary Embolism 2016
Avatar

Prime Time for Reversal Agents: Latest Data, How and When to use Them…and Will They Tilt the Balance in Favor of NOACs over Traditional Agents?

By Pulmonary Embolism 2016 FEATURING George Davis
By Pulmonary Embolism 2016 FEATURING George Davis
0 views
October 17, 2016
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
19:49
Rush University Medical Center

COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Feat. S. Jain
14:59
PERT Consortium 2021

New European Guidelines on Pulmonary Embolism: What Has Changed and …

Feat. S. Konstantinides
57:30
McMaster University Department of Medicine

Five Things Every Internist Should Know About Anticoagulants

Feat. S. Mithoowani
05:31
Pulmonary Embolism 2016

Pulmonary Embolism During Pregnancy

Feat. J. Bartholomew
13:25
TCT 2022 Conference Coverage

TCT 2022: Why Intervene on Submassive Pulmonary Embolism Patients?

Feat. W. Jaber
16:11
Jeffrey Weitz

Extended Anticoagulation for VTE

10:12
Pulmonary Embolism Symposium (PERT 2017)

Long Term Anticoagulation - How and For How Long?

11:39
Mount Sinai Endovascular Fellows Course

Catheter-Based Interventions for Acute Pulmonary Embolism: What Are …

Feat. J. Giri
08:01
PERT Consortium 2022

Update on HI-PEITHO - A Landmark Clinical Trial in PE

Feat. K. Rosenfield
16:54
NYU Langone

Management of Acute Pulmonary Embolism: How Long Do You Treat?

Feat. N. Amoroso
44:26
The North American Thrombosis Forum (NATF)

Panel Discussion: Acute vs Chronic Changes in PE, Anticoagulation Du…

Feat. G. Piazza, J. Rodriguez-Lopez, B. Bikdeli, A. Witkin, F. Rahaghi, A. Wong
05:30
PERT Consortium 2021

Triaging Acute Pulmonary Embolism for Home Treatment or Simplified P…

Feat. M. Huisman
16:51
PERT Consortium 2021

Pathobiology and Medical Management of CTEPH: Panel Discussion

Feat. B. Rivera-Lebron, S. Bartolome, E. Klok, A. Witkin, T. Todoran
13:33
PERT Consortium 2021

PE in the Ambulatory and Hospital Settings: Scope of the Problem

Feat. G. Barnes
24:16
ARCH Advanced Revascularization Symposium

Q&A: Thrombus Management

Feat. K. Rosenfield, S. Mathews, A. G. El-Shafei
14:53
William Peacock

MERCURY-PE Trial: Does the Outpatient Treatment with Rivaroxaban Dec…

13:18
NY Endovascular Summit

Medical Management of PE

Feat. J. Goldfinger
23:27
UPMC

Treatment of Pulmonary Embolism

Feat. B. Schwartz
20:27
University of Miami

PE Interventions: Patient and Device Selection

Feat. S. Afanador
13:50
Courage and Innovation Symposium: Heart Failure & Heart Transplantation

Systematic Approach to Pulmonary Embolism Management

Feat. J. Paul